Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    HR-11-001
Show Display Options
Rank Status Study
1 Completed An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Condition: Malignant Tumors
Intervention: Drug: Gemcitabine HCl Oral Formulation

Indicates status has not been verified in more than two years